Allurion宣布发布新数据，证明患有肥胖的青少年体重减轻;在一项针对91名青少年的研究中，4个月时平均体重减轻13.1%，没有出现严重不良事件

In a study of 91 adolescents, average weight loss was 13.1% at four months with no serious adverse events

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the publication of a study on the safety and effectiveness of the Allurion Program in adolescents.

In the study, 91 adolescents between 15 and 17 years-old with average body mass index (BMI) of 35.6 received the Allurion Balloon and the Allurion Program delivered by a multidisciplinary team, including a trained nutrition professional with adolescent experience. Average weight reduction was 13.1% four months after placement, with no serious adverse events or early device removals.